Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pasithea Therapeutics (NASDAQ: KTTA ) stock is heading higher on Thursday even without any recent news from the biotech company. Source: Bukhta Yurii / Shutterstock.com Strangely enough, there’s no real...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Christmas is almost here but were aren’t slowing down as we dive into the biggest pre-market stock movers for Thursday! Source: Shutterstock Stories moving stocks this morning include re...
MIAMI BEACH, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological dis...
GAINERS: SK Telecom (NYSE:SKM) +74%. Genfit (NASDAQ:GNFT) +59%. Spruce Biosciences (NASDAQ:SPRB) +54%. Stran & Company. Warrant (NASDAQ:STRNW) +34%. Bellerophon Therapeutics (NASDAQ:BLPH) +31%. LOSERS: Pasithea Therapeutics (NASDAQ:KTTA) -17%. Metacrine (N...
Gainers: SK Telecom (NYSE:SKM) +73%. Genfit (NASDAQ:GNFT) +44%. Bellerophon Therapeutics (NASDAQ:BLPH) +27%. Spruce Biosciences (NASDAQ:SPRB) +25%. AMC Entertainment Holdings (NYSE:AMC) +21%. Stran & Company (NASDAQ:STRNW) +22%. AeroCentury (NYSE:ACY) +19%. cbdMD (NYSE:YCBD) +19%. Net 1 U...
-- Pasithea Clinics commences in-home IV ketamine infusion therapy in Florida and Nevada -- -- Treatments conducted by board-certified medical professionals -- -- Expansion to additional U.S. cities in coming months -- MIAMI BEACH, Fla., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Pasit...
MIAMI BEACH, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological di...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The world's stock markets plunged alongside oil prices and U.S. Treasury yields Friday after South Africa raised the alarm over a fast-spread...
Gainers: Biofrontera (NASDAQ:BFRI) +154%. Longeveron (NASDAQ:LGVN) +79%. Ocuphire Pharma (NASDAQ:OCUP) +36%. Society Pass (NASDAQ:SOPA) +24%. Biofrontera (NASDAQ:BFRA) +23%. Better Therapeutics (NASDAQ:BTTX) +20%. Applied UV (NASDAQ:AUVI) +19%. Standard Lithium (NYSE:SLI) +19%. Blue Star Food...
Gainers: Biofrontera (NASDAQ:BFRI) +109%, Longeveron (NASDAQ:LGVN) +87%, Ocuphire Pharma (NASDAQ:OCUP) +41%, Better Therapeutics (NASDAQ:BTTX) +24%, Reviva Pharmaceuticals (NASDAQ:RVPH) +12%. Losers: Vallon Pharmaceuticals (NASDAQ:VLON) -34%, Pasithea Therap...
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
Pasithea Therapeutics Corp. Website:
MIAMI, June 13, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis typ...
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors -- -- PAS-004 inhibition of in vitro NRAS cell lines is greater than selumetinib and binimetinib and similar to trametinib -- -- PAS-004 shows superior activity versus selumetinib and...